ExxonMobil is marking the 100th anniversary of its Mobil Delvac™ lubricant brand, first introduced in 1925 to serve the ...

The clinical hold was lifted as of March 14, 2025, following submission of a complete response letter by vTv Therapeutics which concluded that the chromatographic signal was an experimental artifact.

By Katherine Hamilton Shares of vTv Therapeutics rose after the Food and Drug Administration lifted a clinical hold on its diabetes treatment program. The stock gained 40% to $20.78 Monday morning.

Contribute to ThanhNamLe123/VTV-Logos development by creating an account on GitHub.

VTV officially has the copyright to broadcast EURO 2024. "After a period of negotiation, Vietnam Television and the Viettel Military Industry and Telecommunications Group (Viettel) have reached a ...

“The first quarter of 2024 saw us reach several important milestones, which we believe position vTv well for continued execution of our corporate and clinical development strategy,” said Paul ...

vTv expects to use the proceeds from the PIPE to fund the first Phase 3 study of its lead product candidate, cadisegliatin, which is expected to initiate in mid-2024.

Vanguard Value Index Fund has a long history of outperforming the market with lower return volatility. Check out why VTV ETF is our top pick for 2023.

Looking at the chart above, VTV's low point in its 52 week range is $133.51 per share, with $151.16 as the 52 week high point — that compares with a last trade of $147.90. Comparing the most ...

HIGH POINT, N.C., March 29, 2022 /PRNewswire/ -- vTv Therapeutics Inc. (Nasdaq: VTVT) today reported financial results for the fourth quarter and year ended December 31, 2021, and provided an ...